The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: a meta-analysis

OBJECTIVE: Vortioxetine is a novel antidepressant approved for the treatment of major depressive disorder by the US Food and Drug Administration in September 2013. This meta-analysis assessed the efficacy and safety of different doses of vortioxetine for generalized anxiety disorder of adults. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Jie, Peng, Lilei, Li, Xiaogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844447/
https://www.ncbi.nlm.nih.gov/pubmed/27143896
http://dx.doi.org/10.2147/NDT.S104050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844447/
https://www.ncbi.nlm.nih.gov/pubmed/27143896
http://dx.doi.org/10.2147/NDT.S104050

Ejemplares similares